| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 115.11M | 135.14M | 163.15M | 141.67M | 93.33M | 91.40M |
| Gross Profit | 68.25M | 83.28M | 118.03M | 92.14M | 52.58M | 51.02M |
| EBITDA | 15.28M | 29.36M | 15.77M | 14.89M | 20.90M | 28.04M |
| Net Income | 2.46M | 3.49M | -3.44M | -9.25M | 6.94M | 9.01M |
Balance Sheet | ||||||
| Total Assets | 179.94M | 173.45M | 184.51M | 195.42M | 122.57M | 122.64M |
| Cash, Cash Equivalents and Short-Term Investments | 4.06M | 3.02M | 3.13M | 1.37M | 1.80M | 5.25M |
| Total Debt | 46.25M | 45.46M | 75.50M | 74.33M | 18.45M | 20.82M |
| Total Liabilities | 125.64M | 119.99M | 130.02M | 137.23M | 50.72M | 50.55M |
| Stockholders Equity | 54.30M | 53.45M | 54.48M | 58.19M | 71.85M | 72.09M |
Cash Flow | ||||||
| Free Cash Flow | 10.36M | 20.10M | 12.24M | 6.01M | 13.71M | 13.07M |
| Operating Cash Flow | 19.80M | 29.77M | 22.98M | 12.38M | 16.48M | 15.38M |
| Investing Cash Flow | -10.64M | -11.36M | -11.63M | -32.98M | -7.44M | -2.31M |
| Financing Cash Flow | -9.07M | -18.50M | -9.48M | 18.49M | -12.51M | -11.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £130.33M | 9.36 | 24.53% | 13.93% | -27.01% | -49.07% | |
72 Outperform | £52.29M | 14.63 | 38.65% | 2.69% | 30.01% | 138.65% | |
69 Neutral | £55.61M | 15.19 | 12.27% | ― | 20.40% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £184.79M | 18.70 | 4.57% | 3.01% | -31.46% | 297.44% | |
52 Neutral | £28.63M | -2.77 | -18.74% | ― | -5.84% | 55.30% | |
50 Neutral | £16.56M | -4.40 | -67.57% | ― | -12.11% | -106.04% |
Redcentric has issued 5,620 new ordinary shares following the exercise of employee options granted under its 2014 Save As You Earn plan, reflecting ongoing use of equity-based incentives in its remuneration structure. The new shares are expected to begin trading on AIM around 25 March 2026, bringing total issued share capital to 159,316,719 shares, of which 159,316,223 carry voting rights, a figure investors must now use for regulatory disclosure thresholds.
The small increase in share capital slightly dilutes existing holdings but underscores the company’s continued alignment of staff interests with shareholders through share ownership. For investors and other stakeholders, the updated voting share count is relevant for monitoring significant shareholdings and ensuring compliance with disclosure rules under the FCA’s transparency regime.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £121.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric plc has issued 6,267 new ordinary shares following the exercise of employee share options, with admission of the new shares to trading on AIM expected around 19 March 2026. After the admission, the company’s total issued share capital will rise to 159,311,099 ordinary shares, of which 159,310,603 will constitute the voting share capital once treasury shares are excluded, slightly diluting existing holders but underscoring ongoing use of equity-based staff incentives.
The adjustment in share capital requires investors to use the updated voting share figure when assessing disclosure thresholds under UK transparency rules. This minor capital change reflects routine corporate housekeeping rather than a strategic shift, but it fine-tunes Redcentric’s share register and maintains compliance with regulatory reporting standards.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £124.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric plc has issued 3,747 new ordinary shares following the exercise of employee options under its Save As You Earn 2014 plan, with the new shares expected to commence trading on AIM around 25 February 2026. Following this admission, Redcentric’s total issued share capital will rise to 159,304,832 ordinary shares, of which 159,304,336 carry voting rights after excluding treasury shares, a figure relevant for shareholders monitoring disclosure thresholds under FCA rules.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £123.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric has issued 5,620 new ordinary shares following the exercise of employee options granted under its 2014 Save As You Earn scheme, reflecting ongoing participation in its employee share incentive arrangements. The new shares, expected to begin trading on AIM around 15 January 2026, will increase the company’s total issued share capital to 159,301,085 ordinary shares (of which 159,300,589 carry voting rights), a small technical adjustment that slightly broadens the equity base and updates the reference figure for shareholders’ disclosure obligations under FCA transparency rules.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric plc announced that Non-Executive Director Richard McGuire has increased his stake in the company by purchasing 24,992 ordinary shares at 119.2 pence each, bringing his total holding to 75,000 shares. The director’s share purchase signals strengthened insider confidence in the business and may be viewed positively by investors, underscoring management’s commitment to the company’s prospects as it continues to operate in the competitive UK managed IT services market.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric plc has issued 4,008 new ordinary shares following the exercise of employee options under its 2014 Save As You Earn scheme, with the new shares expected to begin trading on AIM around 6 January 2026. After admission of these shares, Redcentric’s total issued share capital will rise to 159,295,465 ordinary shares, of which 496 are held in treasury, giving a voting share capital of 159,294,969 shares for the purposes of regulatory disclosure thresholds under the FCA’s transparency rules.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric PLC disclosed that non-executive director Richard McGuire has increased his stake in the company by purchasing 29,000 ordinary shares at 118 pence each on 24 December 2025, bringing his total holding to 50,008 shares. The board-level share purchase, conducted on AIM, signals additional director confidence in the company and will be closely watched by investors assessing insider sentiment toward Redcentric’s operational and strategic outlook.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric plc has corrected a previous regulatory announcement regarding a director dealing, confirming that non-executive director Richard McGuire purchased 21,008 ordinary shares at 119 pence each on 23 December 2025. The transaction, conducted on AIM, represents McGuire’s entire current holding and signals personal financial commitment from a board member, a move often closely watched by investors as an indicator of director confidence in the company’s prospects.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric plc has clarified that a previous regulatory announcement on director share dealing contained an error and confirms that non-executive director Richard McGuire purchased 21,008 ordinary shares at 119 pence each on 23 December 2025. The correction ensures accurate disclosure of insider dealings, reinforcing regulatory compliance and transparency for investors regarding board members’ equity positions in the company.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric plc has disclosed that Non-Executive Director Richard McGuire has purchased 21,008 ordinary shares in the company at a price of 16.25 pence per share, representing his current total holding. The director share purchase, executed on 23 December 2025 on AIM, signals board-level confidence in the company and is likely to be closely watched by investors assessing insider sentiment toward Redcentric’s prospects.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.
Redcentric has granted long-term incentive options to its new chief executive, Michelle Senecal De Fonseca, and a notional share option award to non-executive chair Richard McGuire, structured as one-off grants rather than part of an annual programme. The awards, which vest from December 2028 subject to continued service and demanding total shareholder return performance targets, replace the company’s previous practice of granting annual LTIP awards and leave total outstanding options at 7,881,892 shares, or 4.95% of issued share capital, signalling a more focused, performance-linked approach to board remuneration that may impact management incentives and shareholder alignment over the next three years.
The most recent analyst rating on (GB:RCN) stock is a Hold with a £122.00 price target. To see the full list of analyst forecasts on Redcentric stock, see the GB:RCN Stock Forecast page.